文献速递肝病

肝细胞KLF16靶向PPARα改善脂肪性肝炎与胰岛素抵抗

Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance.
PubMed 文献 · Gut · 2020-11-30

本研究探讨肝细胞转录因子KLF16在NAFLD中的作用及机制。KLF16在NAFLD患者、小鼠模型及OA/PA共处理的肝细胞中表达降低。肝细胞KLF16敲除加重脂肪酸氧化障碍、线粒体应激和ROS负荷,促进肝脂肪变和胰岛素抵抗;过表达则通过直接结合PPARα启动子改善上述表型,且PPARα缺失减弱KLF16的保护作用。

要点

  • KLF16在NAFLD患者及小鼠模型中表达降低,与脂肪酸氧化受损相关。
  • 肝细胞KLF16敲除加重肝脂肪变和胰岛素抵抗,过表达则改善。
  • KLF16直接结合PPARα启动子,PPARα缺失削弱其保护作用。

核心结论

  • KLF16-PPARα通路连接肝脏脂质稳态与氧化还原平衡,其功能障碍促进胰岛素抵抗和肝脂肪变。

研究设计与样本

  • 检测NAFLD患者和小鼠模型中KLF16表达,利用肝细胞特异性KLF16缺陷小鼠喂食高脂饮食或通过腺病毒/腺相关病毒改变KLF16表达。
  • 在MPH和体内肝脏中改变KLF16表达,采用RNA-seq、荧光素酶报告基因和ChIP分析探索分子机制。

主要发现

  • KLF16在NAFLD患者、小鼠模型及油酸和棕榈酸共处理的肝细胞中表达降低。
  • 肝细胞KLF16敲除损害脂肪酸氧化,加重线粒体应激、ROS负荷,促进肝脂肪变和胰岛素抵抗。
  • KLF16过表达通过直接结合PPARα启动子加速脂肪酸氧化、减轻线粒体应激和氧化应激,减少脂质沉积并改善胰岛素抵抗。
  • PPARα缺失减弱KLF16在MPH中对脂质沉积的保护作用。
  • 肝细胞特异性PPARα过表达有效挽救KLF16缺失诱导的肝脂肪变、氧化还原平衡改变和胰岛素抵抗。

临床怎么用

  • KLF16-PPARα通路可能作为改善肝脂肪变和胰岛素抵抗的潜在干预靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Impaired hepatic fatty acids oxidation results in lipid accumulation and redox imbalance, promoting the development of fatty liver diseases and insulin resistance. However, the underlying pathogenic mechanism is poorly understood. Krüppel-like factor 16 (KLF16) is a transcription factor that abounds in liver. We explored whether and by what mechanisms KLF16 affects hepatic lipid catabolism to improve hepatosteatosis and insulin resistance. DESIGN: KLF16 expression was determined in patients with non-alcoholic fatty liver disease (NAFLD) and mice models. The role of KLF16 in the regulation of lipid metabolism was investigated using hepatocyte-specific KLF16-deficient mice fed a high-fat diet (HFD) or using an adenovirus/adeno-associated virus to alter KLF16 expression in mouse primary hepatocytes (MPHs) and in vivo livers. RNA-seq, luciferase reporter gene assay and ChIP analysis served to explore the molecular mechanisms involved. RESULTS: KLF16 expression was decreased in patients with NAFLD, mice models and oleic acid and palmitic acid (OA and PA) cochallenged hepatocytes. Hepatic KLF16 knockout impaired fatty acid oxidation, aggravated mitochondrial stress, ROS burden, advancing hepatic steatosis and insulin resistance. Conversely, KLF16 overexpression reduced lipid deposition and improved insulin resistance via directly binding the promoter of peroxisome proliferator-activated receptor α (PPARα) to accelerate fatty acids oxidation and attenuate mitochondrial stress, oxidative stress in db/db and HFD mice. PPARα deficiency diminished the KLF16-evoked protective effects against lipid deposition in MPHs. Hepatic-specific PPARα overexpression effectively rescued KLF16 deficiency-induced hepatic steatosis, altered redox balance and insulin resistance. CONCLUSIONS: These findings prove that a direct KLF16-PPARα pathway closely links hepatic lipid homeostasis and redox balance, whose dysfunction promotes insulin resistance and hepatic steatosis.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Sun N, Shen C, Zhang L, et al. Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance. Gut. 2020. PMID: 33257471. doi:10.1136/gutjnl-2020-321774

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。